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Abstract We describe the QSAR Workbench, a system
for the building and analysis of QSAR models. The system
is built around the Pipeline Pilot workflow tool and pro-
vides access to a variety of model building algorithms for
both continuous and categorical data. Traditionally models
are built on a one by one basis and fully exploring the
model space of algorithms and descriptor subsets is a time
consuming basis. The QSAR Workbench provides a
framework to allow for multiple models to be built over a
number of modeling algorithms, descriptor combinations
and data splits (training and test sets). Methods to analyze
and compare models are provided, enabling the user to
select the most appropriate model. The Workbench pro-
vides a consistent set of routines for data preparation and
chemistry normalization that are also applied for predic-
tions. The Workbench provides a large degree of automa-
tion with the ability to publish preconfigured model
building workflows for a variety of problem domains,
whilst providing experienced users full access to the
underlying parameterization if required. Methods are pro-
vided to allow for publication of selected models as web
services, thus providing integration with the chemistry
desktop. We describe the design and implementation of the
QSAR Workbench and demonstrate its utility through
application to two public domain datasets.
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Introduction
The drug discovery process can be divided into four broad
categories: target identification, lead discovery, lead opti-
mization and drug development. The transition from lead
optimization to drug development involves the selection of
one compound from a series for further evaluation. Thus it
is in the lead optimization phase that the important com-
pound properties are defined. Lead optimization is a multi-
objective process involving many experimental parameters
(assays) relating to target activity, site of action, physico-
chemical properties, target selectivity, off-target activities,
DMPK and toxicity. Pharmaceutical companies have gen-
erated large amounts of data related to many of these end-
points and in silico models for QSARs (quantitative
structure activity relationships) and QSPRs (Quantitative
Structure Property Relationships), can be established to
relate the experimental data to computational parameters
and chemical (sub)structure descriptors [1, 2]. The models
are generated with two end-points in mind: (a) generating
an understanding of the properties or chemical features that
are correlated with the assay in question to aid in com-
pound design and (b) prediction of multiple assays allow-
ing ranking of compounds prior to synthesis. It should be
noted that these two end-points are themselves often in
competition—the most predictive model may not be the
most interpretable [3–5].
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The QSAR model building process can be divided into a
number of steps: data preparation, data normalization,
descriptor calculation, model building, model validation
and model publication. There are guidelines emerging
around how to perform each of these steps [6]. Methods for
alternative descriptor calculation [7] and model building
methods [8] are being sought. However, the over-riding
conclusion from these publications is that no descriptor set
or model building method will be optimal for all circum-
stances. This situation is compounded by the fact that many
of the modeling methods are available in different software
packages with a variety of data formats, front-ends and
model export capabilities. This leads to users tending
towards the systems they know best or which fit most
appropriately with downstream or upstream systems.
Within the context of the pharmaceutical industry, for a
model to be useful it must be built in a timely manner,
retrospective analysis is of only limited utility to a pro-
gram, and it must be possible to apply the model (or
models) within the standard workflow of the program team.
A request from a chemist to a QSAR expert to run a set of
predictions on a list of compounds is unlikely to be
forthcoming unless the modeler is deeply embedded in the
program and can turn around predictions quickly. Better
still, the chemist should work with the modeler to under-
stand which models are appropriate and be able to run them
as required. The number of available assays and related
models coupled with limited expert QSAR resource leads
to a continual conflict between the needs of individual
programs and the development of more widely applicable
global models. There is a need to evaluate any global
model in the context of the particular program and to
update global models as new data are generated.
Thus new approaches to QSAR modeling are required to
address these issues. The DiscoveryBus is one such system
developed to allow for a more automated approach to
model building through competitive workflow [9]. The
AutoQSAR approach can automatically regenerate models
as new data become available [10, 11]. AZOrange is an
Open Source machine learning platform developed at
AstraZeneca [12]. The Automated Modeling Environment
(AME) developed at GlaxoSmithKline is another such
system [13]. AME provided a slice through the whole
modeling workflow, from data gathering from corporate
databases through to model publication. However, the
system required significant resource to maintain and
development and expansion required expert technical skills
beyond most QSAR exponents.
In this paper we describe our experiences of QSAR
modeling within a pharmaceutical setting and illustrate
how these, along with our learning from AME, led us to the
development of the QSAR Workbench, a system for
automated QSAR data preparation, model building, model
validation and model publication. The core of the system is
built using a state-of-the-art workflow tool (Pipeline Pilot
[14]) and, as such, all important parameters are exposed
directly to the QSAR modeler. The system is highly cus-
tomizable as workflows can be modified or new ones cre-
ated. Experts can make available well designed model
building workflows as starting points for different model-
ing scenarios with categorical or continuous data and a
variety of descriptor sets. This is an important feature of
QSAR Workbench as it allows current best practice, as
defined by modeling experts, to be captured and then
redeployed by less experienced users on their own data
sets. The implementation guides the user through the model
building process in a straightforward and logical manner.
The final published models are themselves workflows and
can be published as web services, making them available to
end users through the corporate model prediction web-
service.
The paper proceeds as follows. In the next section we
describe the rationale for our approach, followed by a
summary of the implementation of QSAR Workbench with
more detail in the supporting information. Next we illus-
trate the utility of the system with reference to two public
domain datasets, toxicity endpoints [15–17] from the
CAESAR (Computer Assisted Evaluation of industrial
chemical Substances According to Regulations) project
[18]. Finally, we conclude with a discussion of our lear-
nings and future steps.
Rationale
The pharmaceutical industry, GSK included, has a long
history in the use of QSAR modeling to support the drug
discovery process. The models fall into two broad cate-
gories: (1) global models that are built on diverse datasets
of potentially tens of thousands of data points and are of
general applicability, (2) local models built specifically for
a series or project. Local models may be built on the same
end points as the global models, where for example the
global model is less performant or there is a significant
shift in either the gradient (for a linear model) or the
magnitude of prediction. For example, it is not uncommon
to find series of compounds where the global model pre-
serves the trend but the prediction is shifted. Local models
are also relevant to target and selectivity type modeling.
The individual models may themselves be combined
into other models to guide compound design. An example
is shown in Fig. 1, which illustrates the use of a model of
models to help focus a program into the appropriate regions
of chemical space. It is in such applications that QSAR
experts add real value to the program teams and hence
there is a need to make the building of individual models as
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straightforward as possible without sacrificing quality. This
allows the modeler to focus on the important tasks of
assessing and critiquing models and applying them to real
world problems.
The modeler is faced with a large number of decisions in
relation to model building, choice of descriptors and mod-
eling methods being just two. Figure 2 illustrates the scale
of the problem. Several years ago we undertook an exercise
to evaluate the performance of various modeling methods
and descriptors for modeling of Cytochrome P450 3A4
inhibition. The models showed a range of performance in
terms of specificity and sensitivity, the choice of which
would depend on the application domain. The PLSDA_3-
class model stands out as having a reasonable balance of
specificity and sensitivity, though other models could be
more appropriate in specific applications. Thus the ability to
generate a range of models with multiple modeling meth-
odologies would be advantageous. However, it took many
FTE months of work to generate and analyze these models.
Thus, whilst both these examples are great science they
do not scale. A third issue relates to an earlier point, for a
model to be useful it needs to be both timely and appli-
cable. At GSK we have a SOAP web-service system that
allows us to deploy models that chemists can access
through web-based tools and in applications such as
Helium [19]. There are currently over 50 global models
and a similar number of local models available to aid in
compound design at GSK. Maintaining, validating and
updating these models present significant issues and could
easily take the resource of several highly skilled FTEs. It is
these three factors that have led us to look at mechanisms
for bringing a greater degree of standardization and auto-
mation to the QSAR modeling process.
An interesting perspective on QSAR can be gained by
casting the problem in the light of the CRISP-DM paradigm
[20]. We have used this approach previously when consid-
ering HTS data mining [21]. Within the CRISP-DM model
the process can be broken down into six steps: (1) business
understanding, (2) data understanding, (3) data preparation,
(4) modeling, (5) evaluation, (6) deployment. Clearly steps
(1) and (2) rely on the modeler being closely integrated with
the program team and having a good understanding of which
models are required and how they are being applied. It is our
belief that within a mature field such as QSAR modeling it
should be possible to design systems that can make steps 3, 4
and 6 as straightforward as possible and provide all the
necessary tools and statistics to enable 5. Furthermore, we
would suggest that such a system not only enables good
science but can actually promote better science as the expert
is freed up to focus on the key aspects of the problem and
applying models in real world situations.
AME [13] represented our first approach to building
such a system. This was a fully functional system that took
data from the corporate repository, built models and had
the ability to publish models to the internal web-service.
Using this system we were able to build 11,000 models
across 326 endpoints in a period of weeks. The utility goes
far beyond the individual models, allowing many strategic
questions to be addressed: are there subsets of descriptors
that work best, do some statistical methods work better
than others, are there combinations of descriptors and
methods, do larger data sets lead to better models and so
on? The main problem with AME was one of support-
ability. It required full time IT support to maintain and
implement new methods with the result that the modeler
had the impression of using a black box.
Fig. 1 Example application of
QSAR modeling to direct a
program team to appropriate
regions of chemical space.
A PLS model was built on
models for target activity and
liability end-points (P450s,
hERG). The shaded area was
identified as the most relevant
and the chemistry team was able
to focus its efforts on
synthesizing compounds in this
region
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QSAR Workbench represents our progression to the
next generation of automated QSAR model building that
addresses many of the issues described above. In the
next section we describe the system in more detail, with




A fuller description of the system, with example screen-
shots, is provided in the supporting information. Here we
shall outline the main design objectives and features of the
system. The subsequent example applications provide
some more detail on points of particular relevance.
Our goals in designing the QSAR Workbench were:
(a) to decouple the scientific workflows from the User
Interface so that the QSAR expert could maintain con-
trol over the important features and avoid the black-box;
(b) to provide a rich environment for evaluating and
triaging models; (c) to build individual models rather
than employ competitive modeling workflows or in any
other way automatically select models, the user sees all
models and uses their own judgment, guided by the
plots and statistics, on the most appropriate model for
the intended use; (d) to have the ability to publish
models for general use; (e) to publish validated model
building workflows, or subsets thereof, so that users can
quickly assess the model landscape and gain insight into
what sorts of models and descriptor sets are likely to be
most applicable (if any) to the problem at hand; (f) to
capture the output from the modeling process in a
manner that permits easy communication of how the
model is built, model performance and potentially
important descriptors.
Pipeline Pilot seemed an ideal candidate as an envi-
ronment in which to build the application because of
existing web-service integration, the availability of a
number of QSAR modeling methods, links to third-party
software such as R and a set of rich reporting tools.
Calculations presented in this paper were performed on
a single node of a 64-bit Quad-core Windows laptop with
Intel i7 processors running at 1.73 GHz, with 16 GB
RAM.
Application design
QSAR Workbench is a lightweight Pipeline Pilot web
application that provides an intuitive, user centric, sandbox
environment for building, validating and publishing QSAR
models. Although aimed at workgroup sized teams of
users, the application also provides enterprise scale capa-
bilities such as integration points via Web Services for
existing corporate modeling applications and workflow
capture and replay.
QSAR Workbench is a JavaScript based Rich Internet
Application (RIA) [22, 23] where the majority of the
application’s code resides in the client tier whilst the
server side layer of the application is simply responsible
for providing data (usually formatted as XML, [24] JSON
[25] or HTML [26]) to the client layer, this application
design is commonly referred to as AJAX [27]. QSAR
Workbench makes extensive use of the Pipeline Pilot
Enterprise Server as an application server; for example to
provide JSON formatted data to the client application, as a
scientific modeling platform; to provide services to build
and validate models using several learner algorithms and
also as a reporting server to return HTML formatted data
Fig. 2 Many person months of
effort were required to produce
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to the client. The implementation uses the Pipeline Pilot
Client SDK (Software Development Kit) which allows
communication between the client and Pipeline Pilot via
SOAP [28] Web Services [29] and also several extensions
to the SDK to provide tight integration with a third party
JavaScript library. The workbench utilizes a custom
extension to the Pipeline Pilot reporting collection which
allows for flexible client side validation of HTML forms.
The web application is decoupled from the underlying
modeling workflows. The web forms and computational
processes are created and run by standard Pipeline Pilot
protocols making it straightforward for anyone familiar
with Pipeline Pilot to update and maintain the core science
protocols e.g. to add new descriptors or modeling meth-
ods. The web application locates these protocols from
specific folders on the server, making it possible to add
new processes without modifying the user interface
directly.
QSAR Workbench is organized as a user-based system,
with each user managing a set of projects. On loading a
dataset of structures and endpoint to be modeled the user
has two options. The user can run one of a number of
preconfigured validated protocols that can encapsulate part
or all of the modeling process as described below. Thus
with a single button click the system can build models and
present the results, giving the user feedback on the sys-
tem’s ability to model the endpoint. Alternatively the user
can follow a guided workflow that takes them through each
stage of the process in a more manual and customizable
fashion. The modeling workflow consists of the following
steps: (1) Prepare data, (2) Split data, (3) Descriptors, (4)
Build Model, (5) Validate Model, (6) Publish. We describe
each of these briefly.
Prepare data
This allows the user to apply appropriate desalting,
chemistry normalization and standardization to business
rules compatible with the descriptor definitions. The
response property can be normalized in a number of ways
including scaling to unit variance or log transformation.
Continuous data can be converted to categorical and binary
categories created.
Split data
Several algorithms are provided for splitting the data into
test and validation sets: clustering on chemical fingerprints
or properties, stratification according to activity or random
splits can be generated. Several different methods can be
applied within the scope of the project and models will be
built over all of them. Tools are also provided to visualize
the splits in a user-defined property space and these also
allow the user to generate a manual split if desired.
Descriptors
A full range of standard 1D, 2D and 3D descriptors are
available as listed in the supporting information. These
include physicochemical property calculators, e-State val-
ues, topological indices as provided by standard Pipeline
Pilot components. The system has a user extension allow-
ing the inclusion of additional descriptors and it is
straightforward to replace the standard descriptors, e.g. for
calculated logP, with a preferred version. Once descriptors
are calculated, sets of descriptor subsets can be created and
models can be built over each subset.
Build model
The system provides access to a set of modeling techniques
as shown in Table 1.
These provide access to a range of linear and non-linear
methods. The user can select one or more methods and
models are built over the combination of data splits,
descriptors and modeling methods to provide a matrix of
models. Note that we have taken the decision not to employ
competitive workflows in building these models. The
choice of the appropriate model is left to the user. The
model’s own internal cross-validation or train/test split (if
any) is applied to the QSAR Workbench Training Split
when building the model.
Validate model
This is the most critical part of the process, providing tools
for validating models and evaluating a potentially large
model landscape. The models are applied to the QSAR
Workbench Test Split and a number of statistics and plots
are automatically generated to allow the user to compare
the models. The results view contains summary plots
appropriate to the modeling endpoint (categorical or con-
tinuous). These include a ROC [30] or REC [31] curve and
other plots allowing a quick visualization and assessment
of model performance.
The intention is to provide the user with an overview of
the overall performance of the various model combina-
tions, as well as highlighting potential informative features
such as a particular learner that always models well, or one
model that performs particularly better than the others,
indicating potential over-fitting or other issues. The issue of
finding chance correlations when running such a process
should not be overlooked and these summary plots provide
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some reassurance that you do not end up focusing on one
outlier model that happens to have good statistics by
chance. Below the summary plots is a spreadsheet view
containing more detailed statistics. This is sortable and
allows the user to select models for more detailed analysis.
The detailed view provides a mechanism for comparing a
small number of models and making a choice as to which,
if any, to publish. Validate model also provides methods
for running predictions against additional external valida-
tion sets such as temporal datasets.
Publish
If a model of sufficient quality is obtained, the user can
choose to publish it. This makes the model available to all
users in Pipeline Pilot. More importantly the publishing
process provides access to the model by external web-
services. This uses the fact that Pipeline Pilot protocols are
themselves web-services and protocols are provided to list
published models and apply them to user-supplied datasets.
One of the key features of the QSAR Workbench is the
ability to remember and document the steps taken in
building the model. These steps are applied when pub-
lishing the model so that the same data preparation steps
are automatically applied when making predictions. In
addition, a model report is automatically generated as a
PDF document and also included in the model component
help text. The model report contains full details on the
model building process and performance, thus providing
appropriate documentation for inclusion in electronic Lab
Notebooks and to link from prediction tools to allow users
to see the model details.
In addition to models, users can publish the model
building protocol, consisting of one or more of the sub-
steps involved in creating a model (or models). Thus the
user can publish a protocol that automates just the chem-
istry preparation stage or can build all available models
against a categorical endpoint. These are available to other
users and can be accessed via the front page on loading a
dataset.
Use cases
As an example of the use of the QSAR Workbench we
have chosen to revisit two of the five environmental toxi-
cology endpoints previously modeled as part of the CAE-
SAR initiative [15–18]. We will show how use of the
QSAR Workbench framework can enable practical explo-
ration of a large model space, identifying potential outlier
models, and trends and biases caused by specific descrip-
tors, statistical methods or, more commonly, training/test
set splits. The rich reporting available in the model triage
allows identification of the pros and cons of individual
models beyond standard statistical metrics.
Exploring model space
For the purpose of consistency we have chosen to explore
identical descriptor and training/test set splits for all
models. Each dataset was split into a training set and a test
set at two different percentages for three of the available
algorithms described in the supplementary material. The
algorithms chosen were Random, Individual Clusters
(Optimized) and Random Per Cluster. This results in six
different splits for each endpoint. In addition we have
utilized the training/test set split as defined in the QSAR
Model Report Format (QMRF) submissions for the two
endpoints studied, available from the CAESAR web-site
[32]. Table 2 provides a summary of all splits used, and the
labels used to reference them in subsequent discussion.
To explore descriptor space we have selected a total of
194 2-dimensional descriptors. Full details of the descrip-
tors are provided as supporting information. The total
descriptor set was partitioned into ten descriptor subsets.
Table 3 gives a summary of the descriptor subsets, and the
labels used to reference them in subsequent discussion.
We have employed all relevant statistical model learner
methods for each endpoint as defined in Table 1. For cat-
egorical endpoints there are five methods, for continuous
endpoints four methods.
For each endpoint we have explored the full combina-
torial model space available from the combination of splits,
Table 1 Statistical learners available in QSAR Workbench
Statistical method Categorical Continuous Details
PP Bayes Yes No Naı¨ve Bayes as implemented in Pipeline Pilot [41]
PP RP forest Yes No Recursive partitioning forest model [42] as implemented in Pipeline Pilot
PP RP tree Yes No Recursive partitioning tree model [42] as implemented in Pipeline Pilot
R NN Yes Yes Neural network model as implemented in R package nnet [43]
R SVM Yes Yes Support vector machine model as implemented in R package e1071 [44]
PP PLS No Yes Partial least squares model as implemented in Pipeline Pilot
R PLS No Yes Partial least squares model as implemented in R package pls [45]
326 J Comput Aided Mol Des (2013) 27:321–336
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descriptor subsets and learner methods detailed above. For
categorical endpoints this gives rise to a potential model
space of 350 models, for continuous endpoints 280 models.
The QSAR Workbench also allows a fourth dimension of
model space to be explored, namely the underlying
parameters of the learner methods. However for the sake of
this work we have excluded this dimension, and simply
exploited the default parameters for the underlying Pipeline
Pilot implementation of each method.
Skin sensitization classification models
Assessment of skin sensitization potential is a requirement
under REACH Annex VII. Structural data were provided by
the original authors. The raw data are classified into five cat-
egories: non; weak; moderate, strong; extreme. Though the
majority of statistical methods currently exposed through the
QSAR Workbench are able to build multi class models, we
have chosen to follow the work of Chaudry et al. [15] who
built binary classifiers. All results presented in this work have
been defined using a ‘‘non-sensitizer’’ class containing all
compounds with raw classification ‘‘non’’ or ‘‘weak’’, result-
ing in a total of 108 non-sensitizers and 101 sensitizers. For the
purposes of statistical calculation—e.g. model specificity—
the positive class is defined as ‘‘sensitizer’’ (Fig. 3)
Of the potential 350 models, 346 were successfully
built. Plots of Train versus Test ROC AUC and compara-
tive ROC plots over the successfully built models are
shown in Figs. 4 and 5 respectively. All models are shown
for illustration, however, the interactive triage in the
Workbench means that we would rarely look at the full set
of results in this way, more commonly filtering down to a
few models of interest. From Fig. 4 it is possible to observe
a potential trend in terms of models exhibiting over-fitting.
There is a clear set of models with very high training set
ROC AUC (*1.0) yet a broad range of values for test set
ROC AUC, these are built mostly using the R NN learner
method. The interactive nature of the model triage report
allows selection of a subset of models from the chart.
Selection of the models with a ROC AUC score of *1.0
for the training set and passing these through to the second
step of the model triage report reinforces the impression
given by the comparative chart: of the 39 selected models,
28 were built using the R NN method; 3 with PP Bayes; 8
with R SVM. Analysis of the different train/test set splits
used in these likely over-fit models shows no overall trend,
4 models use From Paper; 10 IndOpt50; 4 IndOpt75; 9
Rand50; 3 Rand75; 4 RPC50; 5 RPC75. Again there is no
obvious trend in the descriptor subsets used, 8 models use
Chi_ECFP6_Estate_FCFP4_MolProps; 7 ECFP6; 4
Estate_molprops; 5 FCFP4; 8 FCFP4_Molprops.
This analysis might lead us to distrust the models built
using the R NN method in the context of this study.
However it is most likely that the reason for this arises
from a sub-optimal choice of learner parameters for mod-
eling this data. In real-life application of the QSAR
Workbench the modeler would almost certainly re-visit this
Table 2 Details of training/test set splits used for all endpoints. For
details of split algorithms see the data set splitting section above and
in the supplementary material





IndOpt50 50 Independent clusters (optimized)
IndOpt75 75 Independent clusters (optimized)
RPC50 50 Random per cluster
RPC75 75 Random per cluster
From Paper 80 As defined in the QMRF
submissions
Table 3 Details of descriptor subsets used for all endpoints. Further details on the descriptors are given in supporting information
Descriptor subset Number of
descriptors
Descriptor subset details
Chi 12 Kier-Hall topological Chi indices [46]
ECFP6 1 Extended connectivity fingerprint with atom type classes, diameter 6 [47]
Estate 161 Electrotopological state values and counts [48–50]
FCFP4 1 Extended connectivity fingerprint with functional type classes, diameter 4 [47]
Molprops 19 A set of simple common molecular properties and counts as implemented in
Pipeline Pilot
Chi_Molprops 31 Combination of subsets Chi and MolProps
ECFP6_Molprops 20 Combination of subsets ECFP6 and MolProps
Estate_Molprops 180 Combination of subsets estate and MolProps
FCFP4_Molprops 20 Combination of subsets FCFP4 and MolProps
Chi_ECFP6_Estate_FCFP4_Molprops 194 Combination of subsets Chi, ECFP6, estate, FCFP4 and MolProps
J Comput Aided Mol Des (2013) 27:321–336 327
123
dimension of model space to understand better the root
cause. Here we shall simply discount these—and other R
NN derived models—from further consideration.
Returning to the first step of the model triage report, we
now investigate the small set of ‘‘best’’ models—those with
high ROC AUC for both training and test sets. Again we look
at the break down of statistical method, training/test set splits
and descriptor subsets. Of the 5 models, 2 are built using PP
Bayes and 3 with R SVM. Considering the training/test set
splits: four use From Paper and one RPC 75. In the descriptor
subset dimension the model breakdown is as follows: three
use Chi_ECFP6_Estate_FCFP4_Molprops; one ECFP6_
Molprops; one FCFP4_Molprops. Though this subset of
models is almost certainly too small to draw any concrete
conclusions, it already raises some suspicions. The training/
test set split From Paper was generated in a very similar
manner to RPC75—‘‘by random but stratified, sampling’’
[15]. Though this mechanism for defining a test set is com-
monly employed, there is a risk of over-emphasizing the
model quality from test set statistics. Because the test set is
selected as a subset of structurally derived clusters, there is
an explicit similarity between the training set and test set.
This lack of independence means one would generally expect
the test set statistics to be of similar quality to the training set.
To examine this effect the QSAR Workbench provides
analysis tools for visualizing the training/test set splits in a
two-dimensional representation of structural similarity (the
Analyze Split task). In Fig. 6 three such plots are shown,
Fig. 3 Model validation and triage view. The view shown is for
categorical models. The summary plot of AUC test versus train is
scaleable. The right-hand plots update with the selected models in the
spreadsheet. Models are grouped by model type and are sortable by
the different columns. Selected models can be progressed to a more
detailed view, providing more information on individual models
Fig. 4 ROC plot for training versus test set for all models built for
the skin sensitization end point
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123
these have been generated using the ECFP_6 fingerprint. It
is immediately obvious that the From Paper and RPC75
splits have very similar distributions, with test set com-
pounds evenly interspersed with training set compounds. In
contrast the IndOpt75 plot shows clear ‘‘islands’’ contain-
ing just training or just test set compounds. So, although
these five ‘‘best’’ models seem to show robust statistics for
both training and test sets, an experienced modeler looking
to build a model with reliable predictive power, may not be
entirely happy with any of them. Thus, we now look at
models with balanced training/test-set statistics in the hope
that the final model would provide greater predictive power
in real-life application.
A ‘‘balanced’’ set of models was selected from step one of
the model triage report. Figure 7 shows the filtered set of
comparative ROC plots for training and test sets. This subset
of 16 models shows no overall trend in terms of statistical
method, containing three models built using PP Bayes; 6
with PP RP Forest; 2 with PP RP Tree; 1 with R NN; 4 with R
SVM. As with the ‘‘best’’ model set, these models do show a
strong preference for training/test set splits defined with
random selection within individual clusters: 12 models use
From Paper; two IndOpt75; two RPC75. The descriptor
subsets used show no major overall trend: 3 use Chi_ECF-
P6_Estate_FCFP4_Molprops; 1 ECFP6_Molprops; 3
Estate; 4 Estate_Molprops; 1 FCFP4; 2 FCFP4_Molprops; 4
Molprops. However it is interesting to note that 12 of the 16
models include the simple set of molecular properties and
property counts—the subset Molprops. This is an appealing
result as these descriptors are simple to interpret—an
important factor in judging the quality of QSAR models
according to the OECD principles [33]. Following the dis-
cussion about the ‘‘best’’ model set, we here chose to set aside
models built using the From Paper and RPC75 splits.
The two remaining models, which both use the Ind-
Opt75 split, and the same learner method (PP RP Tree),
have identical statistical measures, and confusion matrices.
As such the preference would be for the model using the
simplest descriptor subset, MolProps. The confusion matrix
for this model is shown in Fig. 8. An appealing aspect of
the use of the PP RP Tree method is that we can get a direct
understanding of the importance of individual descriptors
to the final model. Table 4 shows the ‘‘Number of Ques-
tions’’ in which each of the 19 descriptors within the
MolProps subset is used, each question representing a
branch within the tree. As can be seen this model could be
further simplified with little loss of quality by only con-
sidering the five most significant descriptors: ALogP;
Molecular_Weight; Num_RotatableBonds; Num_Bonds;
Num_Atoms. Table 5 shows comparative statistics for
several models: this manually selected ‘‘balanced’’
model—using PP RP Tree/IndOpt75/MolProps; the model
with the best test-set ROC AUC—using PP Bayes/From-
Paper/Chi_ECFP6_Estate_FCFP4_MolProps; the pub-
lished model of Chaudry et al. [15].
Bioconcentration factor regression models
Bioconcentration factor (BCF) describes the likelihood of
chemical concentration in organisms due to environmental
exposure to the compound. Assessment of BCF is a
requirement within REACH legislation. We have taken
structural data from the curated data set of Lombardo et al.
[16, 17], published as part of their QMRF submission.
Data preparation, train/test splits and model parameters
were as described above for the Skin Sensitization models.
Of the potential 280 models, all were successfully built. Plots
of Train versus Test R2 and comparative REC plots over the
Fig. 5 Comparative ROC plots
for training and test set for all
models built for the skin
sensitization endpoint. The
color scheme for the models is
the same as that in Fig. 4
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successfully built models, as presented to users in step one of
the model triage report, are shown in Fig. 9. The purpose of
these plots is to give the modeler an overview of relative
model performance and to indicate modeling methods, splits
and/or descriptors that are outliers or may be overfit. There
are issues with using R2 (or any statistical measure) in iso-
lation to select between models, particularly with varying
data set splits and sizes. This is mitigated for by the REC plot
and the inclusion of other statistical parameters such as
RMSE in the sortable table below the plot (as illustrated in
Fig. 3). More detailed analysis is provided in subsequent
visualizations following model selection.
In contrast to the classification models built for the skin
sensitization end-point there are no clear trends, in terms of
over-fitting, observable from these plots. It does appear
however that there are a large number of high quality
Fig. 6 Comparison of data set
splits in chemical space for the
skin sensitization end-point,
using multi-dimensional scaling
plots based on ECFP_6
fingerprint similarity for: From
Paper (left panel); RPC75
(centre panel); IndOpt75 (right
panel). Training set members
are represented by green circles,
test set members by red
triangles
Fig. 7 Filtered set of
comparative ROC plots for
‘‘balanced’’ models for the skin
sensitization end-point
Fig. 8 Confusion matrix for the
skin sensitization model built
using the PP RP Tree learner
method, IndOpt75 training/test
set split and MolProps
descriptor subset
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models that use the R SVM learner. Selection of the best
models and drill-down through step two of the model triage
report confirms this observation. Of the 51 selected models
30 are built using the R SVM learner; 5 with PP PLS; 14
with R NN; 1 with R PLS. Comparison of the distribution
of the different training/test set splits methods shows no
clear trend, with 6 of the 7 methods contributing to this
subset of models: 8 models use Chi_ECFP6_Esta-
te_FCFP4_MolProps; 9 Chi_MolProps; 3 ECFP6_Mol-
Props; 6 Estate; 11 Estate_MolProps; 2 FCFP4_MolProps;
11 MolProps. It is interesting to note that 88 % of these
models are built with descriptor sub-sets containing the
MolProps set of simple molecular properties.
Using the drill-down to fine details of the models avail-
able from step two of the model triage report, allows
identification of poor models which might have been con-
sidered reasonable if simply considering the raw statistical
metrics. An example of such a model is Model_258, this
model was built using R NN learner, Rand75 split method
and ECFCP6_MolProps descriptor subset. The training set
R2 of 0.94 and RMSE of 0.46 is very promising (the vari-
ability in experimental values is 0.45 log units), though the
test set values of 0.62 and 1.24 for R2 and RMSE are less
encouraging. The plots of predicted versus actual response,
shown in Fig. 10, highlight some serious issues with this
model. For both training and test sets the model appears to
have strict upper and lower boundaries on predictions.
We now analyze the distribution of the different learner
algorithms, training test set splits and descriptor subsets, for
three hierarchical subsets of models, with increasing test set
R2. 175 models have a test set R2 of 0.70 or better, but there
appears to be no overall trend. Of these models 43 are built
using PP PLS; 30 with R NN; 49 with R PLS; 53 with R SVM.
Considering the different training/test set splits: 28 use From
Paper; 15 IndOpt50; 16 IndOpt75; 29 Rand75; 29 Rand75;
29 RPC50; 29 RPC75. The distribution of descriptor subsets
used is: 5 use the Chi subset; 18 Chi_ECFP6_Esta-
te_FCFP4_MolProps; 25 Chi_MolProps; 2 ECFP6; 20
ECFP6_MolProps; 22 Estate; 25 Estate_MolProps; 12
FCFP4; 20 FCFP4_MolProps; 16 MolProps. We next con-
sider the subset of these models that have a test set R2 of 0.80
or better, 79 models. Of these models 16 are built using PP
PLS; 16 with R NN; 11 with R PLS; 36 with R SVM. Con-
sidering the different training/test set splits: 12 use From
Paper; 2 IndOpt50; 9 Rand50; 12 Rand75; 21 RPC50; 23
RPC75. The distribution of descriptor subsets used is: 9 use
the Chi_ECFP6_Estate_FCFP4_MolProps split; 13
Chi_MolProps; 10 ECFP6_MolProps; 12 Estate; 13
Estate_MolProps; 9 FCFP4_MolProps; 13 MolProps.
Finally reducing this subset to only consider models with test
set R2 of 0.85 or better leaves us with just 25 models. Of these
models one is built using PP PLS; 4 with R NN; 20 with R
SVM. Considering the different training/test set splits: 4 use
FromPaper; 5 Rand50; 4 Rand75; 4 RPC50; 7 RPC75. The
distribution of descriptor subsets used is: 4 use the
Chi_ECFP6_Estate_FCFP4_MolProps split; 5 Chi_Mol-
Props; 4 Estate; 4 Estate_MolProps; 8 MolProps.
As the set of models retained is reduced across the three
cut-offs for test set R2 we can begin to identify some
trends. Firstly in terms of the ‘‘best’’ learner method, the R
SVM method clearly stands out, being used in 30, 46 and
Table 4 Frequency of descriptor usage in the skin sensitization
model built using PP RP tree method, IndOpt75 split and the Mol-
props descriptor subset




















Table 5 Comparison of model statistics for selected models for the skin sensitization end-point. See main text for details of model selection








PP RP Tree/IndOpt75/MolProps 0.79 0.67 0.64 0.70
PP Bayes/From Paper/
Chi_ECFP6_Estate_FCFP4_MolProps
0.86 0.93 0.67 0.90
Chaudry et al. [15] 0.85 0.87 0.70 0.67
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80 % of the models for the 0.70, 0.80 and 0.85 cut-offs
respectively. The frequency that we see use of the different
splits, follows what is probably an unsurprising trend, with
the number of models using either of the IndOpt methods
falling from 18 % at the 0.70 cut-off to 2.5 % at the 0.80
cut-off, and no models using this method at the 0.85 cut-
off. As discussed in the analysis of the results for the skin
sensitization model, the IndOpt split selection method
explicitly attempts to make the test set ‘‘look’’ different (in
terms of chemistry space) to the training set. The split
methods that ensure that the test set do look similar to the
training set tend to out-perform the IndOpt method, when
considering test set statistics. These methods include the
RPC splits, and the From Paper split—which in this case is
an 80:20 random selection [16]. The QSAR Workbench
Analyze Splits tasks can again be used to compare to
known methods. Figure 11 shows comparison of four split
methods for the BCF data set. Though not as pronounced as
in the skin sensitization example, the plot for the IndOpt75
split does show islands of compounds in the test set sep-
arated from any compounds in the training set, for example
the five compounds on the far right of the plot, and a
smaller island on the top-left of the plot. There are again
marked similarities between the plots for the From Paper
and RPC75 splits. There does not appear to be any major
trend in the distribution of descriptor sub-sets used across
the increasingly more accurate model sub-sets, though it is
again pleasing to note that all but 4 of the most accurate 25
models include, at least in part, the simple MolProps
descriptor subset.
Table 6 shows the training and test set R2 and RMSE for
four models: the model published by Lombardo et al.; the
best model (in terms of test set R2) found using the From
Paper split; a ‘‘balanced’’ model, which uses the IndOpt
split method, thus eliminating explicit bias towards
improved test set statistics; the best model (in terms of R2)
found excluding those built with either the From Paper or
RPC split methods, in this case using the Rand75 split
Fig. 9 Training set versus test set R2 (left) and REC plot over all models built for the BCF endpoint
Fig. 10 Actual versus predicted
regression plots for Model_258,
for the BCF end-point. Results
for the training set are shown on
the left, results for the test set on
the right. This is an example of
a poor model even though the
model statistics appear
reasonable
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method, where it is not entirely clear what bias may have
been introduced. It should be noted that the model of
Lombardo et al. is actually a composite model composed of
two different predictors. In addition a domain of applica-
bility test was employed so that not all compounds in the
test set were included in the statistics of the published
model. All of the models created for this work use the R
SVM learner, two of the three use just the MolProps
descriptor sub-set, the other the Chi_MolProps subset. All
of these models show very reasonable statistics, as such it
would probably be appealing to use the one without bias in
the test-set statistics for real-life application. Figure 12
shows the actual versus predicted regression plots for
training and test sets for this finally selected model.
Discussion and conclusions
The QSAR Workbench encapsulates the workflow required
to build, validate, analyze and publish QSAR models. The
intended users are QSAR model experts, where the system
provides a framework to build and explore a range of
configuration and model building parameters, and modelers
with an understanding of the principles of QSAR but per-
haps with less familiarity of the various algorithms and
software packages available.
The system can be used in a highly automated fashion
through the configuration of appropriate default settings for
different modeling scenarios: continuous, categorical,
multi-class data sets. These different scenarios would
normally require expert parameterization and set up using a
variety of bespoke and/or 3rd party software but through
the Workbench the appropriate best practice can now be
embedded into saved workflows for immediate selection
and replay on new data sets of similar nature by users with
only limited knowledge of QSAR. Thus even the relatively
inexperienced modeler will be capable of exploring good
quality QSAR solutions to their data with the confidence
that the modeling has been appropriately set up. In this
scenario the system can provide a rapid assessment of
whether a particular dataset is amenable to QSAR model-
ing and point the user to model subspaces worthy of further
Fig. 11 Comparison of data set
splits in chemical space for the
BCF end-point, using multi-
dimensional scaling plots based
on ECFP_6 fingerprint




members are represented by
green circles, test set members
by red triangles
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exploration. In the use cases presented in this work, the
human set-up time to build the approximately 600 QSAR
models was under one hour, once the model spaces have
been built the modeler is able to concentrate on the analysis
of the models.
The publication capabilities of the QSAR Workbench
provide mechanisms for capturing modeling protocols. The
Workbench also provides access to the important descrip-
tors as allowed by the various modeling algorithms. In
addition, published models include auto generated help text
that embeds the model building and validation details.
Thus those wishing to utilize the models can understand the
finer details of the process. The published models are
available by default as calculable properties in Pipeline
Pilot and integration with other workflow tools or inter-
faces is possible through the use of web-services and two
additional protocols have been written to this end.
However, the QSAR Workbench is not a black-box
system and provides the flexibility to drill down to the
detail of any particular step or, indeed, to build individual
models in a bespoke manner. Important aspects of the data
preparation such as chemistry normalization are handled in
a consistent and flexible manner and the use of standard
workflows makes the system extensible and highly cus-
tomizable. Thus, the system enables the model builder to
focus on the important aspects of model validation and
analysis rather than data manipulation and the requirements
of disparate software packages.
As the example applications above have shown the user
can then start to answer questions such as: why did this
model outperform others? Are there combinations of
models and descriptors that are working better? How stable
are the models to the pretreatment and parameterization?
The results show that with reasonable default settings and
protocols the QSAR Workbench can produce models that
are equivalent in terms of performance to what might be
considered as state-of-the-art models for the specific end-
points considered.
The use of large scale automated modeling also raises
several challenges or opportunities. As described earlier,
the decision was made at the outset not to include any form
of competitive workflow into the model building process.
Nevertheless the possibility of chance correlation should
not be overlooked. The Workbench enforces good model-
ing practice and provides a number of features to mitigate
this risk, as mentioned in the Implementation section when
describing model validation. The emphasis on plots and
interactive triage highlights a particular model as being an
outlier if other similarly built models all appear worse. The
Split algorithms to create Test sets of increasing difficulty
also help as it is unlikely that a much better model would
be derived from a whole cluster based selection than from
Table 6 Comparison of model statistics for selected models for the BCF end-point. See main text for details of model selection
Model details Training set R2 Training set RMSE Test set R2 Test set RMSE
Lombardo et al. 0.85 0.53 0.83 0.51
R SVM/Rand75/Chi_MolProps 0.93 0.49 0.88 0.65
R SVM/FromPaper/MolProps 0.93 0.50 0.86 0.68
R SVM/IndOpt50/MolProps 0.93 0.52 0.81 0.70
Fig. 12 Actual versus predicted
regression plots for Model_80,
for the BCF end-point. Results
for the training set are shown on
the left, results for the test set on
the right. Model_80 was built
using R SVM, IndOpt50 split
and MolProps descriptor subset
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say a Randomized or Diverse selection. Indeed the whole
cluster (approximating to a leave-class-out validation) has
been described as pessimistic by some experts [34]. A
completely independent hold out set is used for model
validation. The true test of a model is a further ‘completely
independent’ and probably temporal set [34] which would
be the last gate a model would pass through prior to pro-
duction deployment. There are additional approaches that
can be taken to help identify such chance correlations and
the latest version of the Workbench includes options for
additional model cross-validation (outside of that used in a
particular modeling approach) and Y-scrambling.
The availability of a large number of models from dif-
ferent methodologies provides a pool of models for an
ensemble modeling approach. The creation of such models,
with increased predictive power, through methods such as
data fusion are well established [35]. When models, that
have independence in the predicted errors, are combined in
this way then the average predictive value should approach
the true value as the square of the number of models
included in the ensemble. Though such methods offer a
clear route to improved predictions, there is almost always
an associated reduction in the ability to interpret the
resulting ensemble model. This situation is akin to the use
of a Random Forest of recursive partitioning trees. The
version of QSAR Workbench used in the preparation of
this work does not contain any functionality to generate
such ensemble models; however we believe that the choice
of the Pipeline Pilot framework provides the flexibility to
allow this to be rapidly implemented. In fact a recent
update to the QSAR Workbench includes an interactive
graphical report allowing users to ‘‘drill down’’ to the
individual predictions across a sub-set of models, for an
external data-set. In this way a manual set of models
suitable for combination into an ensemble could be selec-
ted, following the general philosophy of the Workbench
that the QSAR expert can bring value to the model selec-
tion process.
Another important factor when considering the utility of
a model in providing predictions to medicinal chemists in
an industrial setting is the quantification of the domain of
applicability of the model. Ideally a QSAR model predic-
tion would also come with an associated estimate of the
error of prediction. In practical usage of global models in a
drug discovery program setting, the continued verification
of the model performance is good practice. This can
highlight systematic variation (a slope or intercept shift) or
cases where the global model breaks down and a local
model can be built as more information becomes available.
Such activities are made more tractable by having an
appropriate modeling infrastructure as presented here.
There have been a number of recent efforts to derive
quantitative measures of applicability domain of QSAR
models [6, 36–38]. Generally these utilize a measure of
‘‘distance’’ to the training set, from simple Euclidean
measures to more advanced methods like the Mahalanobis
distance. The underlying Pipeline Pilot learner compo-
nents exploited in the current version of the QSAR
Workbench all have the ability to provide some measure
of applicability domain along with the prediction. These
include warnings when descriptors are out of range of
those seen in the training set, or outside the Optimal
Prediction Space [39] as well as other measures such as
Mahalanobis distance. Provision of estimates of errors in
prediction could also be derived from these measures [40].
Currently no explicit reporting of these metrics is per-
formed in the QSAR Workbench. The advantages of an
implementation in a workflow tool such as Pipeline Pilot
opposed to compiled code in a product are particularly
evident in such cases where the science is not well
developed and could become fast moving as implemen-
tation (and subsequent removal) of one or more such
methods is straightforward.
In conclusion, we have presented the QSAR Work-
bench. A workflow based system for automated high-
throughput model building based on local expert specifi-
cations. The Workbench interfaces to a range of model
building methodologies and provides graphical tools for
navigating and triaging the resulting model space. This
allows for identification of outlier models or methods that
are tending to over-fit in a particular scenario and identi-
fication of trends in the data pretreatment (data set split-
ting) amongst others. The system integrates directly with
the chemist desktop through the publication of models as
web-services and is extensible and maintainable through
the extensive use of Pipeline Pilot workflows to build the
main work protocols. The examples presented show that
the system is capable of building robust, high quality
models in an automated fashion. With this infrastructure in
place we are now in a position to exploit the full value from
enterprise wide QSAR modeling across all endpoints of
interest to drug discovery programs.
Supporting information
The full list of descriptors and the relevant groupings used
in building the models. A full description of the QSAR
Workbench system. This material is available free of
charge via the link below.
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